Quanterix Corporation (QTRX)
| Market Cap | 2.45B |
| Revenue (ttm) | 76.16M |
| Net Income (ttm) | -32.67M |
| Shares Out | 30.14M |
| EPS (ttm) | -1.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 2 |
| Last Price | $77.10 |
| Previous Close | $82.66 |
| Change ($) | -5.56 |
| Change (%) | -6.73% |
| Day's Open | 83.65 |
| Day's Range | 75.69 - 83.75 |
| Day's Volume | 406,520 |
| 52-Week Range | 10.89 - 92.57 |
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will releas...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chie...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has commenc...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Exe...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today provided operational and prel...
Shares of Quanterix Corp. rallied nearly 10% in the extended session Monday after the life-sciences company said the Food and Drug Administration has issued an emergency use authorization for ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Dr...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and D...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Appoints William Geist as Chief Operating Officer
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Exe...
Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call Transcript
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, ...
Quanterix: Still Bullish But Valuation Less Compelling
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into...
Quanterix's industry leading platform, which is highly levered to the growth in precision medicine, can detect protein biomarkers at significantly lower concentrations and at higher sensitivit...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its ...
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2020 Results - Earnings Call Transcript
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2020 Results - Earnings Call Transcript
Quanterix (QTRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2019 Results - Earnings Call Transcript
Quanterix Corp (QTRX) CEO Kevin Hrusovsky on Q3 2019 Results - Earnings Call Transcript
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2019 Results - Earnings Call Transcript
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2019 Results - Earnings Call Transcript
About QTRX
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa p... [Read more...]
| Industry Medical Devices | IPO Date Dec 7, 2017 |
| CEO E. Kevin Hrusovsky | Employees 248 |
| Stock Exchange NASDAQ | Ticker Symbol QTRX |
Financial Performance
In 2019, Quanterix's revenue was $56.73 million, an increase of 50.76% compared to the previous year's $37.63 million. Losses were -$40.80 million, 29.4% more than in 2018.
Analyst Forecasts
According to 5 analysts, the average rating for Quanterix stock is "Strong Buy." The 12-month stock price forecast is 72.00, which is a decrease of -6.61% from the latest price.